NASDAQ: SUPNSupernus Pharmaceuticals Inc Stock Ownership - Who owns Supernus Pharmaceuticals?
Insider buying vs selling
Have Supernus Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Charles W. Newhall Iii | Director | 2023-11-16 | 2,500 | $28.01 | $70.03kSell |
| Charles W. Newhall Iii | Director | 2023-11-16 | 7,457 | $9.24 | $68.90kBuy |
| Frederick M. Hudson | Director | 2023-11-15 | 3,882 | $28.50 | $110.64kSell |
| Frederick M. Hudson | Director | 2023-11-15 | 5,211 | $28.50 | $148.51kSell |
| Frederick M. Hudson | Director | 2023-11-15 | 7,457 | $9.24 | $68.90kBuy |
| Frank Mottola | SVP Quality GMP Ops IT | 2023-11-14 | 1,110 | $28.13 | $31.22kSell |
| Frank Mottola | SVP Quality GMP Ops IT | 2023-11-14 | 2,000 | $9.24 | $18.48kBuy |
| Timothy C. Dec | Senior Vice-President CFO | 2023-10-13 | 1,911 | $26.91 | $51.43kSell |
| Jack A. Khattar | President CEO | 2023-09-07 | 16,804 | $32.10 | $539.41kSell |
| Padmanabh P. Bhatt | Sr. VP of IP CSO | 2023-09-07 | 1,182 | $32.10 | $37.94kSell |
SUPN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SUPN insiders and whales buy or sell their stock.
SUPN Shareholders
What type of owners hold Supernus Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Peter J. Barris | 21.71% | 11,859,518 | $319.14M | Insider |
| Scott D. Sandell | 21.52% | 11,757,336 | $316.39M | Insider |
| Forest Baskett | 21.50% | 11,746,274 | $316.09M | Insider |
| Charles W. Newhall Iii | 19.69% | 10,758,339 | $289.51M | Insider |
| Blackrock Inc | 18.63% | 10,179,905 | $273.94M | Institution |
| Vanguard Group Inc | 11.11% | 6,072,180 | $163.40M | Institution |
| Armistice Capital LLC | 9.32% | 5,092,000 | $137.03M | Institution |
| Krishna Kittu Kolluri | 7.03% | 3,841,172 | $103.37M | Insider |
| New Enterprise Associates 11 LP | 6.99% | 3,820,625 | $102.81M | Insider |
| Nea Partners 11 LP | 6.99% | 3,820,625 | $102.81M | Insider |
SUPN vs Pharmaceutical Stocks
Supernus Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.